Biostar Pharmaceuticals Inc (NASDAQ:BSPM)

1.14
Delayed Data
As of May 22
 +0.01 / +0.88%
Today’s Change
0.91
Today|||52-Week Range
2.27
-2.56%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$17.6M

Company Description

BioStar Pharmaceuticals, Inc., develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The company's products include AoXing Oleanlic Acid Capsule (treatment for Hepatitis B), Danshen Granule (treatment for coronory heart disease, myocarditis and angina pectoris), GanWang (treatment for colds, runny nose, sore throat, headache and fever), Taohuasan (treatment for bronchial congestion and coughs) and Tianqi Dysmenorrhea Capsule (treatment for dysmenorrhea). BioStar Pharmaceuticals was founded on March 27, 2007 and is headquartered in Xianyang, China.

Contact Information

BioStar Pharmaceuticals, Inc.
No. 588 Shiji Xi Avenue
Xianyang Shaanxi 712046
P:862933685888
Investor Relations:

Employees

Shareholders

Other institutional4.44%
Individual stakeholders0.06%
Mutual fund holders0.00%

Top Executives

Rong Hua WangChairman & Chief Executive Officer
Zheng Hong WangChief Operating Officer
Qing Hua LiuChief Financial Officer & Director
Gong ShuangSecretary & Administration Director
Xiaohui ZhengChief Scientist

To view my watchlist

Not a member yet?

Sign up now for a free account